Remove 2014 Remove Document Remove Pharmaceutical
article thumbnail

Shaping the Future of Biotech Trials: An Interview with John Moller, CEO of Novotech

Frost & Sullivan Manufacturing

In this exclusive conversation, John Moller , CEO of Novotech , shares how the companys Asia-Pacific roots, global expansion strategy, and deep biotech specialization position it to become the CRO of choice for biotech and small to mid-sized pharmaceutical companies worldwide. Morgan, Bio-Asia, and Bio-IT World.